UA100772C2 - N-[(1z)-2-[(2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-yl)amino]-2-oxo-1-(2-oxo-1,2-dihydro-3h-indole-3-ylidene)ethyl]benzamide exhibiting anabolic action - Google Patents

N-[(1z)-2-[(2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-yl)amino]-2-oxo-1-(2-oxo-1,2-dihydro-3h-indole-3-ylidene)ethyl]benzamide exhibiting anabolic action

Info

Publication number
UA100772C2
UA100772C2 UAA201104098A UAA201104098A UA100772C2 UA 100772 C2 UA100772 C2 UA 100772C2 UA A201104098 A UAA201104098 A UA A201104098A UA A201104098 A UAA201104098 A UA A201104098A UA 100772 C2 UA100772 C2 UA 100772C2
Authority
UA
Ukraine
Prior art keywords
oxo
tetrahydropyrimidine
ylidene
dioxo
benzamide
Prior art date
Application number
UAA201104098A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Марианна Александровна Алексеева
Александр Александрович Алтухов
Сергей Викторович Колиснык
Константин Михайлович Сытник
Алла Ильинична Березнякова
Валерий Васильевич Болотов
Original Assignee
Национальный Фармацевтический Университет
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Национальный Фармацевтический Университет filed Critical Национальный Фармацевтический Университет
Priority to UAA201104098A priority Critical patent/UA100772C2/en
Publication of UA100772C2 publication Critical patent/UA100772C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to chemico-pharmaceutical industry, in particular to chemical compounds with biological activity that exhibit anabolic action without androgenic activity at low toxicity and can be used as active substance in pharmaceutical preparations of different dosage forms.Disclosed is a compound N-[(1Z)-2-[(2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-yl)amino]-2-oxo-1-(2-oxo-1,2-dihydro-3H-indole-3-ylidene)ethyl]benzamide of general formula,exhibiting anabolic action.
UAA201104098A 2011-04-05 2011-04-05 N-[(1z)-2-[(2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-yl)amino]-2-oxo-1-(2-oxo-1,2-dihydro-3h-indole-3-ylidene)ethyl]benzamide exhibiting anabolic action UA100772C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAA201104098A UA100772C2 (en) 2011-04-05 2011-04-05 N-[(1z)-2-[(2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-yl)amino]-2-oxo-1-(2-oxo-1,2-dihydro-3h-indole-3-ylidene)ethyl]benzamide exhibiting anabolic action

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAA201104098A UA100772C2 (en) 2011-04-05 2011-04-05 N-[(1z)-2-[(2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-yl)amino]-2-oxo-1-(2-oxo-1,2-dihydro-3h-indole-3-ylidene)ethyl]benzamide exhibiting anabolic action

Publications (1)

Publication Number Publication Date
UA100772C2 true UA100772C2 (en) 2013-01-25

Family

ID=51584510

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201104098A UA100772C2 (en) 2011-04-05 2011-04-05 N-[(1z)-2-[(2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-yl)amino]-2-oxo-1-(2-oxo-1,2-dihydro-3h-indole-3-ylidene)ethyl]benzamide exhibiting anabolic action

Country Status (1)

Country Link
UA (1) UA100772C2 (en)

Similar Documents

Publication Publication Date Title
MY169377A (en) Benzamide derivatives for inhibiting the activity of abl1, abl2 and bcr-abl1
MX2015003653A (en) Benzoimidazole-carboxylic acid amide derivatives as apj receptor modulators.
BR112014027181A2 (en) benzamide derivatives for inhibition of abl1, abl2 and bcr-abl1 activity
EA201391786A1 (en) HALOGEN-ALKYL-1,3-OXAZINS AS BACE1 AND / OR BACE2 INHIBITORS
BR112014027244A2 (en) benzamide derivatives for inhibition of abl1, abl2 and bcr-abl1 activity
TR201904614T4 (en) Novel pyrazole derivative.
EA201391098A1 (en) C-28-AMINES C-3-MODIFIED BETULINIC DERIVATIVE DERIVATIVES AS AN HIV INHIBITORS INHIBITORS
MY171146A (en) Compositions of glp-1 peptides and preparation thereof
MX2014001067A (en) Inhibitors of influenza viruses replication.
EA201300200A1 (en) N - ((6-AMINOPIRIDIN-3-IL) METHYL) HETEROARILKARBOXAMIDES AS KALLYCREIN INHIBITORS IN PLASMA
AU2012259422A8 (en) Solid forms of a pharmaceutically active substance
MX2009004233A (en) Biaryl ether urea compounds.
EA201500448A1 (en) GUANIDINE CONNECTION
PH12014502863A1 (en) Liquid preparations of amines and organic acids stabilized by salts
EA201201050A1 (en) PYRAZOLES AS AN ANTAGONISTS CRTH2
ATE500222T1 (en) BENZAMIDE AND HETEROARE DERIVATIVES AS CETP INHIBITORS
MD20120050A2 (en) New agomelatine cocrystals, process for their preparation and pharmaceutical compositions containing them
BR112014007578A2 (en) carbamate / urea derivatives containing piperidine and piperazine rings as h3 receptor inhibitors
MX362059B (en) Carbamate/urea derivatives.
MX336333B (en) New crystalline form of a cyclopropyl benzamide derivative.
MX2013002208A (en) Sulfonylpiperazine derivatives that interact with glucokinase regulatory protein for the treatment of diabetes.
EA201490573A1 (en) CONTAINING BENZOTHIAZOLONE
UA100772C2 (en) N-[(1z)-2-[(2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-yl)amino]-2-oxo-1-(2-oxo-1,2-dihydro-3h-indole-3-ylidene)ethyl]benzamide exhibiting anabolic action
EA201400365A1 (en) NEW THYRODUCT LACTS AS HIGHLY ACTIVE HDAC INHIBITORS AND THEIR APPLICATION AS MEDICINES
CR20130522A (en) INHIBITORS OF THE PEPTIDE DESFORMILASA